Support Connection Hosts Educational Webinar For Women With Ovarian Cancer

  • Comment
Dr. David Spriggs
Dr. David Spriggs Photo Credit: Memorial Sloan Kettering Cancer Center

YORKTOWN HEIGHTS, N.Y. -- Support Connection, Inc. will host a free educational webinar for women with ovarian cancer.

It will take place on Tuesday, Sept. 23, from 8 p.m. to 9 p.m. 

This free program is available to women nationwide. For those without computer access, it is also possible to participate via toll-free teleconference. The program is being held in September in recognition of National Ovarian Cancer Awareness Month.

The speaker is Dr. David Spriggs, of Memorial Sloan Kettering Cancer Center. Spriggs is head of the division of solid tumor oncology and Winthrop Rockefeller chair of medical oncology.

The webinar will focus on issues pertaining to women with ovarian cancer, including those experiencing a recurrence. Topics will include: The latest information in the development of drugs for advanced ovarian cancer; advances in immune therapy. A question and answer period will follow. Discussion will be facilitated by a Support Connection staff member.

The program is free. Women interested in participating should call Support Connection in advance to register and receive instructions. To learn more or to register, call Support Connection at 914-962-6402 or 1-800-532-4290.

This program is presented by Support Connection as part of their 2014 “Tune In and Take Charge!” campaign.

In addition to the daily care of women with gynecologic cancers, Spriggs runs clinical trials testing new, targeted drugs, and oversees a small research laboratory looking for answers to questions such as why certain tumors resist drug treatment and how genes can affect the development of tumors.

Spriggs serves on committees for the National Cancer Institute and plays a role on the editorial boards of such publications as Investigational New Drugs, Gynecologic Oncology and Clinical Cancer Research. He is the associate editor of the Journal of Clinical Oncology.
 

  • Comment

Comments